Bavarian Nordic A/S (BVNRY)
OTCMKTS · Delayed Price · Currency is USD
12.17
+0.21 (1.76%)
Aug 1, 2025, 3:47 PM EDT
Exscientia Revenue
Bavarian Nordic had revenue of 1.35B DKK in the quarter ending March 31, 2025, with 61.95% growth. This brings the company's revenue in the last twelve months to 6.23B, down -6.18% year-over-year. In the year 2024, Bavarian Nordic had annual revenue of 5.72B, down -19.06%.
Revenue (ttm)
6.23B DKK
Revenue Growth
-6.18%
P/S Ratio
3.14
Revenue / Employee
3.88M DKK
Employees
1,605
Market Cap
2.83B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.72B | -1.35B | -19.06% |
Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Bavarian Nordic News
- 1 day ago - Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance - GlobeNewsWire
- 5 days ago - Bavarian Nordic agrees to $2.99B takeover by Permira and Nordic Capital - Seeking Alpha
- 5 days ago - Bavarian Nordic Agrees to $2.99 Billion Private-Equity Takeover - The Wall Street Journal
- 5 days ago - Consortium led by Nordic Capital, Permira to acquire Bavarian Nordic - Reuters
- 5 days ago - Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended Purchase Offer for Bavarian Nordic - GlobeNewsWire
- 8 days ago - Bavarian Nordic climbs after buyout offer - Seeking Alpha
- 8 days ago - Permira, Nordic in Takeover Talks for Vaccine Maker Bavarian - Financial Post
- 8 days ago - Bavarian Nordic in talks with Nordic Capital and Permira on potential takeover - Reuters